ULBP4 is a novel ligand for human NKG2D
- 24 April 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 305 (1) , 129-135
- https://doi.org/10.1016/s0006-291x(03)00714-9
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Human Cytomegalovirus Glycoprotein UL16 Causes Intracellular Sequestration of NKG2D Ligands, Protecting Against Natural Killer Cell CytotoxicityThe Journal of Experimental Medicine, 2003
- A Cluster of Ten Novel MHC Class I Related Genes on Human Chromosome 6q24.2–q25.3Genomics, 2002
- Regulation of Cutaneous Malignancy by γδ T CellsScience, 2001
- MICA Engagement by Human Vγ2Vδ2 T Cells Enhances Their Antigen-Dependent Effector FunctionImmunity, 2001
- ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cellsEuropean Journal of Immunology, 2001
- ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D ReceptorPublished by Elsevier ,2001
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999
- REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORSAnnual Review of Immunology, 1999
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- NK CELL RECEPTORSAnnual Review of Immunology, 1998